Who invested in Kalaris Therapeutics?
Kalaris Therapeutics's investors include Fidelity, Redmile Group, Samsara BioCapital and RTW Investments LLC.
United States · Funded startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2025, from 1 source
Kalaris Therapeutics's investors include Fidelity, Redmile Group, Samsara BioCapital and RTW Investments LLC.
Kalaris Therapeutics has raised $50M across 1 round since 2025.
Kalaris Therapeutics's most recent round was an Undisclosed round of $50M in Dec 2025.
Its most recent round, $50M in Dec 2025, is also its largest on record.
Kalaris Therapeutics's first round on record, in Dec 2025, was backed by Fidelity, Redmile Group and Samsara BioCapital and 1 others.
Kalaris Therapeutics's latest named round is an Undisclosed round, in Dec 2025.
Kalaris Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.